Regan D. McCormick

Regan D. McCormick

Auto-generated profile, based on publicly available information

Regan D. McCormick

Department of Microbiology University of Georgia Athens Georgia USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2023 in Molecular Microbiology
Verified
Journal Article
Open access
APAnastacia Parks
Anastacia Parks
RMRegan D. McCormick
Regan D. McCormick
JBJordan A. Byrne
Jordan A. Byrne
JEJorge C Escalante-Semerena
Jorge C Escalante-Semerena
The enteropathogen Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) utilizes a cluster of genes encoded within the pathogenicity island 2 (SPI-2) of its genome to proliferate inside macrophages. The expression of SPI-2 is controlled by a complex network of transcriptional regulators and environmental cues, which now include a recently characterized DNA-binding protein named PagR. Growth of S. Typhimurium in low-phosphate, low-magnesium medium mimics conditions inside macrophages. Under such conditions, PagR ensures SPI-2 induction by upregulating the transcription of slyA, which encodes a known activator of SPI-2. Here, we report that PagR represses the expression of a divergently transcribed polycistronic operon that encodes the two subunits of transketolase TktC (i.e., tktD, tktE) of this bacterium. Transketolases contribute to the nonredox rearrangements of phosphorylated sugars of the pentose phosphate pathway, which provide building blocks for amino acids, nucleotides, cofactors, etc. We also demonstrate that PagR represses the expression of its own gene and define two PagR-binding sites between stm2344 and pagR.

5 June 2026 in Molecular Microbiology
Verified
Journal Article
Open access
RMRegan D. McCormick
Regan D. McCormick
AJAatif A. Jabbar
Aatif A. Jabbar
JEJorge C Escalante-Semerena
Jorge C Escalante-Semerena
The first step in the metabolic utilization of ribose is the phosphorylation of its 5′ hydroxyl group. The enteropathogenic bacterium Salmonella enterica subsp. enterica sv. Typhimurium str. LT2 (hereafter S. Typhimurium) has two known enzymes that can phosphorylate D‐ribose, namely ribose kinase (RbsK) and deoxyribose kinase (DeoK). Here, we report in vivo and in vitro evidence to support the conclusion that the previously uncharacterized STM3547 protein of this bacterium has ribose kinase activity, and we propose naming it RikA (Ribokinase A). Our bioinformatics analyses show end‐to‐end sequence identity/similarity among RikA, RbsK, and DeoK, and site‐directed mutagenesis of RikA showed that, like in RbsK and DeoK, an aspartate residue (position 343 in RikA) is critical for enzymatic activity. We found that RikA has K m values comparable to those of RbsK and DeoK for both ribose and ATP, and that all three proteins display cooperative binding of ATP induced by ribose. Together, these data suggest that the ribose‐induced conformational changes observed in E. coli RbsK also occur in all three ribose kinases of S. typhimurium . Notably, while RikA has robust ribose kinase activity, it can only poorly phosphorylate 2‐deoxy‐D‐ribose, D‐xylose, and D‐xylulose, and it cannot phosphorylate L‐arabinose. Collectively, our data support the conclusion that the RikA protein is a member of the phosphofructose kinase B‐type (PfkB) family of sugar kinases.